Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update

Rhea-AI Summary

Editas Medicine (Nasdaq: EDIT) announced a conference call and webcast on May 5, 2021, at 8:00 a.m. ET to discuss the first quarter results and provide a corporate update. Interested parties can join the call by dialing (844) 348-3801 for toll-free access or (213) 358-0955 for international access. The conference ID is 7587147. The webcast will also be available on Editas Medicine's website. Editas focuses on developing CRISPR-based genomic therapies for serious diseases, aiming to translate genome editing technology into effective treatments.

CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, May 5, 2021, at 8:00 a.m. ET to discuss a corporate update and results for the first quarter of 2021.

Conference Call & Webcast Details
Date:	Wednesday, May 5, 2021
Time:	8:00 am Eastern Time
Toll Free:	(844) 348-3801
International:	(213) 358-0955
Conference ID:	7587147
Webcast:	https://edge.media-server.com/mmc/p/vfqo9b5q

The live webcast of the conference call can also be accessed in the Investors section of Editas Medicine website at https://www.editasmedicine.com/.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

Investors
Ron Moldaver
(617) 401-9052
ir@editasmed.com

FAQ

When will Editas Medicine announce its first quarter results?

Editas Medicine will announce its first quarter results on May 5, 2021.

What time is the Editas Medicine conference call scheduled?

The Editas Medicine conference call is scheduled for 8:00 a.m. ET on May 5, 2021.

How can I access the Editas Medicine conference call?

You can access the Editas Medicine conference call by calling (844) 348-3801 for toll-free access or (213) 358-0955 for international access, using conference ID 7587147.

Where can I find the webcast for the Editas Medicine conference call?

The webcast for the Editas Medicine conference call can be found on their official website.

What is the focus of Editas Medicine?

Editas Medicine focuses on developing genomic therapies using CRISPR technology for serious diseases.